Alzheimers Medicine

Alzheimer's disease, a progressive neurodegenerative disorder, currently lacks a cure but several medications aim to alleviate symptoms and slow progression. Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, enhance communication among brain cells by preserving acetylcholine, a neurotransmitter crucial for memory and learning. Another class, NMDA receptor antagonists like memantine, regulates glutamate activity to mitigate symptoms like confusion and memory loss. Emerging research explores potential treatments targeting amyloid plaques and tau tangles, hallmark brain abnormalities in Alzheimer's. These include monoclonal antibodies like aducanumab, designed to clear amyloid plaques, and tau-targeting therapies. While these treatments offer hope, ongoing research aims to better understand Alzheimer's complex mechanisms to develop more effective therapies.